The University of Chicago Header Logo

Connection

Girish Venkataraman to Programmed Cell Death 1 Receptor

Back to Details
This is a "connection" page, showing publications Girish Venkataraman has written about Programmed Cell Death 1 Receptor.
Girish Venkataraman
Connection Strength
0.384
Programmed Cell Death 1 Receptor
  1. TIGIT is a key inhibitory checkpoint receptor in lymphoma. J Immunother Cancer. 2023 06; 11(6).
    View in: PubMed
    Score: 0.198
  2. TP53/PLCG2-mutated diffuse large B-cell lymphoma richter transformation (DLBCL-RT) of CLL with unusual CD2 and PD-1 expression. Leuk Lymphoma. 2022 11; 63(11):2735-2738.
    View in: PubMed
    Score: 0.186
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.